Wikidata entity: Q414873
C₁₉H₂₁N₃O₅ (P274)
Quantities
| P4250 | defined daily dose | 5 |
| P2067 | mass | 371.148 |
| P233 | canonical SMILES | String | CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC | ??? |
| P373 | Commons category | String | Isradipine | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2175 | medical condition treated | ... | Q41861 (arterial hypertension) | arterial hypertension |
| P2175 | medical condition treated | ... | Q180762 (angina pectoris) | angina pectoris |
| P129 | physically interacts with | ... | Q14905748 (Calcium channel, voltage-dependent, L type, alpha 1C subunit) | Calcium channel, voltage-dependent, L type, alpha 1C subunit |
| P129 | physically interacts with | ... | Q21102124 (Calcium voltage-gated channel subunit alpha1 F) | Calcium voltage-gated channel subunit alpha1 F |
| P129 | physically interacts with | ... | Q21102146 (Calcium voltage-gated channel subunit alpha1 D) | Calcium voltage-gated channel subunit alpha1 D |
| P129 | physically interacts with | ... | Q21984383 (Voltage-dependent L-type calcium channel subunit alpha-1F) | Voltage-dependent L-type calcium channel subunit alpha-1F |
| P279 | subclass of | ... | Q49858617 (dihydropyridine) | dihydropyridine |
| P2868 | subject has role | ... | Q421700 (calcium channel blocker) | calcium channel blocker |
| P2868 | subject has role | ... | Q575890 (antihypertensive drug) | antihypertensive drug |
| P2868 | subject has role | ... | Q4008956 (vasodilator agent) | vasodilator agent |
Why not click here or view trends?
log id: 5920699